NCT02926950 Efficacy and Safety of Sotagliflozin Versus Placebo in Patients With Type 2 Diabetes Mellitus on Background of Metformin Status COMPLETED Phase PHASE3
NCT02926937 Efficacy and Safety of Sotagliflozin Versus Placebo in Patients With Type 2 Diabetes Mellitus Not Currently Treated With Antidiabetic Therapy Status COMPLETED Phase PHASE3
NCT02921971 Effectiveness and Safety of SAR156597 in Treating Diffuse Systemic Sclerosis Status COMPLETED Phase PHASE2
NCT02914886 Beneficial Effect of Insulin Glulisine by Lipoatrophy and Type 1 Diabetes (LAS) Status COMPLETED Phase PHASE4
NCT02912468 A Controlled Clinical Study of Dupilumab in Patients With Bilateral Nasal Polyps Status COMPLETED Phase PHASE3
NCT02910518 A Study to Demonstrate Bioequivalence Between Insulin Glulisine U300 and Insulin Glulisine U100 After a Single Subcutaneous Dose Using the Euglycemic Clamp Technique, in Patients With Type 1 Diabetes Mellitus Status COMPLETED Phase PHASE1
NCT02903160 Prostate Cancer Intensive, Non-Cross Reactive Therapy (PRINT) for Castration Resistant Prostate Cancer (CRPC) Status COMPLETED Phase PHASE2
NCT02898454 Controlled Clinical Study of Dupilumab in Patients With Nasal Polyps Status COMPLETED Phase PHASE3
NCT02890992 An 8-Week Dose-Finding Study to Evaluate the Efficacy and Safety of Alirocumab in Children and Adolescents With Heterozygous Familial Hypercholesterolemia Status COMPLETED Phase PHASE2
NCT02890147 Molecular Reclassification to Find Clinically Useful Biomarkers for Systemic Autoimmune Diseases: Case-control Status COMPLETED Phase N/A
NCT02890134 Molecular Reclassification to Find Clinically Useful Biomarkers for Systemic Autoimmune Diseases: Inception Cohort Status COMPLETED Phase N/A
NCT02890121 Molecular Reclassification to Find Clinically Useful Biomarkers for Systemic Autoimmune Diseases: Status COMPLETED Phase N/A
NCT02882178 Consensus Method to Evaluate the Conformity of Prescription of a Chemotherapy Status COMPLETED Phase N/A
NCT02878603 Follow-up Study for Patients Who Completed Study ALX0681-C301 (Post-HERCULES) Status COMPLETED Phase PHASE3
NCT02859896 Safety and Efficacy of Hectorol in Pediatric Patients With Chronic Kidney Disease Stage 3 and 4 With Secondary Hyperparathyroidism Not Yet on Dialysis Status TERMINATED Phase PHASE3
NCT02855684 Comparison of the Efficacy and Safety of a New Formulation of Insulin Glargine With Lantus in Patients With Type 2 Diabetes Insufficiently Controlled With Non-insulin Antidiabetic Therapy Status COMPLETED Phase PHASE3
NCT02844582 Cabazitaxel and Prednisone in Treating Patients With Metastatic Hormone-Resistant Prostate Cancer Status TERMINATED Phase PHASE2
NCT02842359 Evaluation of the Fixed-dose Combination of Irbesartan/Atorvastatin in Type 2 Diabetic Patients Diagnosed With Hyperlipidemia and Hypertension Status COMPLETED Phase PHASE4
NCT02836704 Comparison of Standard vs Higher Starting Dose of Insulin Glargine in Chinese Patients With Type 2 Diabetes (Glargine Starting Dose) Status COMPLETED Phase PHASE4